NCT06503341 A Hospital-Based Registry of Preventive Cardiology Clinics
| NCT ID | NCT06503341 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Cardiovascular Diseases, Pakistan |
| Condition | Cardiovascular Morbidity |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2021-06-17 |
| Primary Completion | 2031-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2021-06-17 with a primary completion date of 2031-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
More research is needed to articulate the most effective ways to use these tools as screening tests in cardiovascular risk assessments and how they ultimately affect CVD mortality and morbidity outcomes. Clinicians are encouraged to continue sharing decision-making with patients to combine their unique cardiovascular risk factors and develop a comprehensive, effective treatment plan.
Eligibility Criteria
Inclusion Criteria: * All individuals attending the preventive cardiology clinics. Exclusion Criteria: * • Individuals who refused to give consent.
Contact & Investigator
Dr Rubina Rauf
PRINCIPAL INVESTIGATOR
National Institute of Cardiovascular Diseases
Frequently Asked Questions
Who can join the NCT06503341 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Cardiovascular Morbidity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06503341 currently recruiting?
Yes, NCT06503341 is actively recruiting participants. Contact the research team at drrubinarauf@gmail.com for enrollment information.
Where is the NCT06503341 trial being conducted?
This trial is being conducted at Karachi, Pakistan.
Who is sponsoring the NCT06503341 clinical trial?
NCT06503341 is sponsored by National Institute of Cardiovascular Diseases, Pakistan. The principal investigator is Dr Rubina Rauf at National Institute of Cardiovascular Diseases. The trial plans to enroll 10,000 participants.